|
31 Jul 2025 |
Krsnaa Diagnostics
|
Consensus Share Price Target
|
861.30 |
1053.00 |
- |
22.26 |
buy
|
|
|
|
|
19 Feb 2025
|
Krsnaa Diagnostics
|
Khambatta Securities
|
861.30
|
995.00
|
708.85
(21.51%)
|
15.52 |
Buy
|
|
|
Krsnaa Diagnostics Limited’s (KDL’s) revenue decreased due to seasonal
factors and temporary operational issues. The Mumbai BMC project ended
earlier than expected, and the Maharashtra city and Madhya Pradesh MRI
installations experienced delays due to site handover issues which led to a
temporary dip in revenues.
|
|
31 Oct 2024
|
Krsnaa Diagnostics
|
Ventura
|
861.30
|
1741.00
|
941.85
(-8.55%)
|
102.14 |
Buy
|
|
|
Bridging the Gap: Quality Diagnostics at Fair Prices
|
|
30 Oct 2024
|
Krsnaa Diagnostics
|
Khambatta Securities
|
861.30
|
970.00
|
950.70
(-9.40%)
|
Target met |
Hold
|
|
|
Krsnaa Diagnostics Limited (KDL) reported robust business growth in 2Q FY25. The company has its growth projection of 25% for the financial year.
|
|
23 Aug 2024
|
Krsnaa Diagnostics
|
Khambatta Securities
|
861.30
|
781.00
|
728.25
(18.27%)
|
Target met |
Hold
|
|
|
Krsnaa Diagnostics Limited’s (KDL’s) business growth remained healthy on a y-o-y basis. That said, the growth was lower than expectations.
|
|
13 Feb 2022
|
Krsnaa Diagnostics
|
Khambatta Securities
|
861.30
|
1115.00
|
602.95
(42.85%)
|
|
Buy
|
|
|
|
|
03 Jan 2022
|
Krsnaa Diagnostics
|
Khambatta Securities
|
861.30
|
1117.00
|
755.85
(13.95%)
|
|
Buy
|
|
|
|
|
04 Aug 2021
|
Krsnaa Diagnostics
|
HDFC Securities
|
861.30
|
|
|
|
IPO Note
|
|
|
Krsnaa Diagnostics Limited IPO Note Issue Open: Aug 04 Aug 06 2021 Price Band: Rs. 933 954 (Discount of Rs 93 for the eligible employees) *Issue Size: 12,718,392 eq shares (Fresh Issue of 400 cr + Offer for sale of 8,525,520 eq sh) Issue Size: Rs.1186.6 1213.3 cr Reservation for: QIB atleast 75% eq sh Non Institutional atleast 15% eq sh Retail Upto 10% eq sh
|
|
04 Aug 2021
|
Krsnaa Diagnostics
|
Ashika Research
|
861.30
|
|
|
|
IPO Note
|
|
|
15 Equity Shares and in multiples thereof. Public issue of 12,718,392 Equity shares of Face value Rs. 5 each, (Comprising of fresh issue of 4,192,872 Equity Shares* (Rs. 400 cr.) and Offer for Sale of...
|
|
04 Aug 2021
|
Krsnaa Diagnostics
|
Ventura
|
861.30
|
|
|
|
IPO Note
|
|
|
|
|
03 Aug 2021
|
Krsnaa Diagnostics
|
ICICI Securities Limited
|
861.30
|
|
|
|
IPO Note
|
|
|
The company believes it provides quality services at competitive rates while following accreditations and protocols in line with best industry practice. For example, the cost of radiology tests it provides is 45-60% lower than market rates while the cost of pathology tests are 40-60% lower than market rate. Long term contracts for better visibility The terms of contract with public health agencies ranges between two and 10 years and typically include a term extension clause based on performance and mutual agreement. Further, considering services at...
|